Mankind Pharma to invest Rs 200cr to open 2 plants by mid-2016 Pooja30 Nov 2015 10:18 AM ISTNew Delhi, Nov 29 (PTI) Drug firm Mankind Pharma will invest Rs 200 crore to open two manufacturing plants in the country by the middle of 2016 as...
Cipla inks investment pact with FIL Capital Investments Meghna A Singhania29 Nov 2015 1:29 PM ISTNew Delhi : Cipla today said it has inked an investment agreement with FIL Capital Investments (Mauritius) II Limited for its consumer healthcare...
Cipla weighs legal options after Delhi HC's patent ruling Meghna A Singhania29 Nov 2015 1:26 PM ISTNew Delhi: Drug major Cipla is exploring all legal options in the wake of Delhi High Court's ruling that it has infringed Swiss drug major Hoffman-La...
FDA declines expanded approval for Bristol-Myers' Opdivo drug Pooja28 Nov 2015 9:56 AM ISTBristol-Myers Squibb Co said the U.S. Food and Drug Administration declined to approve its immuno-oncology drug, Opdivo, for its expanded use to treat...
Cipla infringing Roche's patent in lung cancer drug: HC Pooja28 Nov 2015 9:49 AM ISTIn a setback to Cipla, the Delhi High Court today held that the Indian drug major was infringing Swiss pharmaceutical company Hoffman-La Roche's...
'Withdrawl of Tax Exemption to Negatively Impact Innovation' savita26 Nov 2015 4:16 PM ISTHYDEABAD:Â Withdrawal of tax exemption for research and development is likely to negatively impact India's innovation efforts, pharma major Dr Reddy's...
Allergan drops appeal of order blocking Alzheimer's drug switch Pooja26 Nov 2015 10:11 AM ISTAllergan PLC said on Wednesday it will not appeal to the U.S. Supreme Court a court ruling this year that blocked the company from discontinuing its...
Lupin gets USFDA nod for generic oral contraceptive tablets Pooja25 Nov 2015 10:21 AM ISTNew Delhi, Nov 24 : Lupin today said it has received US health regulator's final approval to market Blisovi oral contraceptive tablets in different...
Mankind Pharma launches diabetes drug 'Dynaglipt' Pooja24 Nov 2015 10:05 AM ISTNew Delhi, Nov 23 : Mankind Pharma has launched an anti-diabetic product 'Dynaglipt' targeting the middle class and rural diabetic patients.The...
Novartis gets FDA approval for skin cancer drug combination savita23 Nov 2015 5:14 PM ISTNovartis AG said on Friday it received the U.S. Food and Drug Administration's regular approval for a drug combination to treat an aggressive form of...
Sanofi, AstraZeneca in major drug-sharing deal savita23 Nov 2015 5:10 PM ISTFrench pharmaceutical company Sanofi and Britain's AstraZeneca said  they have agreed to share freely 210,000 proprietary chemical compounds as they...
FDA approves Takeda drug for blood cancer multiple myeloma savita23 Nov 2015 4:27 PM ISTThe U.S. Food and Drug Administration on Friday approved a third drug to treat multiple myeloma, a type of blood cancer.The approved pill, called...
